139 related articles for article (PubMed ID: 33443863)
1. Confirmation of NKX3-1 Expression in EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma Using Monoclonal Antibody Immunohistochemistry, RT-PCR, and RNA In Situ Hybridization.
Yoshida A; Hashimoto T; Ryo E; Yoshida KI; Motoi T; Yatabe Y; Mori T
Am J Surg Pathol; 2021 Apr; 45(4):578-582. PubMed ID: 33443863
[No Abstract] [Full Text] [Related]
2. NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma.
Yoshida KI; Machado I; Motoi T; Parafioriti A; Lacambra M; Ichikawa H; Kawai A; Antonescu CR; Yoshida A
Am J Surg Pathol; 2020 Jun; 44(6):719-728. PubMed ID: 31972596
[TBL] [Abstract][Full Text] [Related]
3. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
Syed M; Mushtaq S; Loya A; Hassan U
Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic utility of cytology specimen in a case of EWSR1::NFATC2 sarcoma.
Takeda N; Makise N; Kageyama H; Takahashi T; Katoh H; Odaka A; Oikawa M; Sugiyama T; Kawana H; Araki A; Kinoshita H; Hagiwara Y; Kamoda H; Yonemoto T; Itami M
Virchows Arch; 2024 Mar; 484(3):533-538. PubMed ID: 38483612
[TBL] [Abstract][Full Text] [Related]
5. Expanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors: A Common Genomic Abnormality in Vascular Malformation/Hemangioma and Simple Bone Cyst.
Ong SLM; Lam SW; van den Akker BEWM; Kroon HM; Briaire-de Bruijn IH; Cleven AHG; Savci-Heijink DC; Cleton-Jansen AM; Baumhoer D; Szuhai K; Bovée JVMG
Am J Surg Pathol; 2021 Dec; 45(12):1669-1681. PubMed ID: 34081036
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
[TBL] [Abstract][Full Text] [Related]
7. Sarcomas with EWSR1::Non-ETS Fusion (EWSR1::NFATC2 and EWSR1::PATZ1).
Machado I; Llombart-Bosch A; Charville GW; Navarro S; Domínguez Franjo MP; Bridge JA; Linos K
Surg Pathol Clin; 2024 Mar; 17(1):31-55. PubMed ID: 38278606
[TBL] [Abstract][Full Text] [Related]
8. Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging
Brcic I; Scheipl S; Bergovec M; Leithner A; Szkandera J; Sotlar K; Suda AJ; Smolle MA; Kraus T; Rosenberg AE; Liegl-Atzwanger B; Igrec J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555836
[TBL] [Abstract][Full Text] [Related]
9. FUS-NFATC2 or EWSR1-NFATC2 Fusions Are Present in a Large Proportion of Simple Bone Cysts.
Pižem J; Šekoranja D; Zupan A; Boštjančič E; Matjašič A; Mavčič B; Contreras JA; Gazič B; Martinčič D; Snoj Ž; Limpel Novak KA; Salapura V
Am J Surg Pathol; 2020 Dec; 44(12):1623-1634. PubMed ID: 32991339
[TBL] [Abstract][Full Text] [Related]
10. EWSR1/FUS-NFATc2 rearranged round cell sarcoma: clinicopathological series of 4 cases and literature review.
Diaz-Perez JA; Nielsen GP; Antonescu C; Taylor MS; Lozano-Calderon SA; Rosenberg AE
Hum Pathol; 2019 Aug; 90():45-53. PubMed ID: 31078563
[TBL] [Abstract][Full Text] [Related]
11. Identification of EWSR1-NFATC2 fusion in simple bone cysts.
Hung YP; Fisch AS; Diaz-Perez JA; Iafrate AJ; Lennerz JK; Nardi V; Bredella MA; Raskin KA; Lozano-Calderon SA; Rosenberg AE; Nielsen GP
Histopathology; 2021 May; 78(6):849-856. PubMed ID: 33316098
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
[TBL] [Abstract][Full Text] [Related]
13. Skeletal EWSR1-NFATC2 sarcoma previously diagnosed as Ewing-like adamantinoma: A case report and literature review emphasizing its unique radiological features.
Makise N; Yoshida KI; Iijima T; Yoshida A; Ushiku T; Ishida T
Pathol Int; 2021 Sep; 71(9):614-620. PubMed ID: 34192825
[TBL] [Abstract][Full Text] [Related]
14. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.
Szuhai K; Ijszenga M; de Jong D; Karseladze A; Tanke HJ; Hogendoorn PC
Clin Cancer Res; 2009 Apr; 15(7):2259-68. PubMed ID: 19318479
[TBL] [Abstract][Full Text] [Related]
15. EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.
Wang GY; Thomas DG; Davis JL; Ng T; Patel RM; Harms PW; Betz BL; Schuetze SM; McHugh JB; Horvai AE; Cho SJ; Lucas DR
Am J Surg Pathol; 2019 Aug; 43(8):1112-1122. PubMed ID: 30994538
[TBL] [Abstract][Full Text] [Related]
16. A novel FUS::NFATC4 fusion detected in a sarcoma with morphological features overlapping with NFATC2 sarcomas.
Klubíčková N; Gross JM; Comová K; Kuruc J; Michal M
Histopathology; 2024 Jan; 84(2):413-415. PubMed ID: 37813649
[No Abstract] [Full Text] [Related]
17. Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.
Rekhi B; Vogel U; Basak R; Desai SB; Jambhekar NA
Pathol Oncol Res; 2014 Jul; 20(3):503-16. PubMed ID: 24293381
[TBL] [Abstract][Full Text] [Related]
18. Soft tissue round cell sarcoma of the abdominal wall, with EWSR1-non-ETS fusion (EWSR1-NFATC2 sarcoma): A case report and literature review emphasizing its clinical features.
Tsuchie H; Umakoshi M; Hasegawa T; Nagasawa H; Okada K; Nanjyo H; Goto A; Miyakoshi N
J Orthop Sci; 2024 Jan; 29(1):374-378. PubMed ID: 35430129
[No Abstract] [Full Text] [Related]
19. Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor.
Segawa K; Sugita S; Aoyama T; Kubo T; Asanuma H; Sugawara T; Ito Y; Tsujiwaki M; Fujita H; Emori M; Hasegawa T
Diagn Pathol; 2018 Sep; 13(1):73. PubMed ID: 30219084
[TBL] [Abstract][Full Text] [Related]
20. NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker.
Perret R; Escuriol J; Velasco V; Mayeur L; Soubeyran I; Delfour C; Aubert S; Polivka M; Karanian M; Meurgey A; Le Guellec S; Weingertner N; Hoeller S; Coindre JM; Larousserie F; Pierron G; Tirode F; Le Loarer F
Mod Pathol; 2020 Oct; 33(10):1930-1944. PubMed ID: 32327700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
